BRAF and hairy cell leukemia: Investigations into the role of mutated BRAF V600E in HCL found constitutive activation of the RAF-MEK-ERK mitogen-activated protein kinase (MAPK) pathway secondary to unregulated phosphorylation of the BRAF kinase targets MEK and ERK.